Is Ketamine A Stimulant?
Last reviewed and updated: June 24, 2026.
Key Takeaways
| What it is | Dissociative anesthetic — NMDA glutamate receptor antagonist; NOT a stimulant, depressant, or classical hallucinogen; Schedule III |
| Why it feels activating | Stimulates sympathetic nervous system at clinical doses (increases HR/BP) — unlike other anesthetics; some patients feel energized or mentally activated |
| Antidepressant mechanism | NMDA blockade → AMPA glutamate burst → BDNF release → synaptogenesis; works within hours; effective for SSRI non-responders |
| IV vs Spravato | Spravato (esketamine nasal): FDA-approved TRD/MDD+SI, insurance-covered; IV ketamine: off-label, out-of-pocket (~$3k–$8k series) |
| Addiction risk | Real but lower risk in monitored clinical settings; bladder damage risk with chronic heavy recreational use; screen for SUD history |
One in five Americans suffer from a mental illness, with depression alone impacting nearly 21 million adults in the U.S. in 2020. With more people needing and seeking mental health care, there has been a growing interest in alternative mental health treatments. This includes using ketamine for therapy.
The prevalence of treatment-resistant mental health issues like treatment-resistant depression is another driving force in the advancements of psychedelics and increased interest in treatments like ketamine therapy. Some estimates claim that a third of patients with major depressive disorder have treatment-resistant depression. But promising research indicates that ketamine may be a solution to the issue.
With more than 1,800 ketamine clinics across the U.S. this encouraging alternative treatment is certainly growing in popularity. Still, with every new alternative treatment option comes a host of questions and concerns. Questioning available mental health treatments is a healthy habit, and investigating as much as you can about every treatment option is key to a better experience.
Here, we explore this promising treatment for mental health issues and learn whether or not ketamine is a stimulant and what this means for patient health and outcomes.
In this article, we answer some of the following questions:
- What is ketamine?
- What is a stimulant?
- Is ketamine a stimulant?
- How does ketamine therapy work?
RELATED: Ketamine Experiences: What Happens If It Doesn’t Work?
What Is Ketamine?
Ketamine was originally synthesized in 1962 by an organic chemist called Calvin Stevens. It was used at first as an anesthetic for animals. Later, it was proven effective for humans and it entered the medical world, becoming a hospital staple and even being used in the field during the Vietnam War to manage pain and shock in wounded soldiers.
Gaining FDA approval as an anesthetic in 1970, today it’s commonly used for pain relief outside the operating room. Ketamine’s ability to induce sleep, relieve pain, and cause short-term memory loss make it a widely popular anesthetic in the medical world.
Since ketamine is soluble in water and in lipids (oils), it can be taken in a range of forms including through the bloodstream, into the muscle, and into bone. It can also be found in the form of a nasal spray, lozenges, or as oral tablets.
In the 2000s ketamine’s ability to ease depression started becoming apparent to doctors, and so, research into ketamine therapy began. Today, mental health professionals use ketamine to treat mental health issues including treatment-resistant depression, anxiety, PTSD, OCD, and addiction.
Is Ketamine A Stimulant?
No. Ketamine is a dissociative anesthetic, not a stimulant. This means that it induces anesthesia in high enough doses. The dissociative aspect of ketamine means that it distorts the senses of sight and hearing, and causes patients to feel disconnected from their surroundings or reality. It essentially induces a dream-like state and can trigger deep relaxation if used correctly.
Ketamine’s frequent use has been recreationally because of its ability to put users into a dream-like trance. When being used unsupervised or mixed with other substances, it can be fatal. This is why using ketamine should be in an environment like trustworthy ketamine clinics. This way, a professional can monitor clients.
While ketamine is dissociative and not a stimulant, it can have stimulant effects — especially in low doses, such as those used in ketamine therapy. Patients report an enhanced sense of wellbeing and a sense of happiness, which are effects of both stimulants and dissociatives alike.
However, there are many differences.
While stimulants increase alertness, dissociatives like ketamine increase relaxation, and cause users to feel floaty, numb, pain-free, safe, and unaware in comparison.
RELATED: How Ketamine Treatment For Anxiety Works, Per Medical Experts
Ketamine Is Not A Stimulant, So What Is A Stimulant?
A stimulant is any substance that speeds up communication between the brain and the rest of the body. Commonly referred to as ‘uppers’ they cause a person to feel more alert, energetic, and confident. In low doses, stimulants can cause euphoria and a heightened sense of wellbeing. Ketamine is known to have this effect on patients.
In higher doses, stimulants can cause the following:
- Anxiety
- Tension
- Nausea
- Seizures
Stimulants also often increase heart rate and blood pressure, while and reducing appetite.
Stimulants are commonly thought of as party substances. However, things like caffeine and nicotine are both household stimulants, and are easily accessible.
If you are considering ketamine therapy to treat chronic pain or mental health issues, you make be asking, is ketamine a stimulant or something else?
How Does Ketamine Therapy Work?
An estimated 70 percent of people who try ketamine therapy for mental health concerns benefit from it long-term and researchers are looking into the reasons behind this.
In some people with depression, neurons in the brain don’t communicate with each other. This is because they don’t get excited by neurotransmitters (the chemicals impacting communication) the way they should. Ketamine helps the nerve cells to communicate better by helping them get more receptors to effectively pass on neurotransmitters. Essentially, ketamine helps regrow synapses that depressed people may have lost through stress.
While traditional antidepressants can take multiple weeks before having any effect on depression, the effects of ketamine start immediately, with patients reporting an improved mood and relief straight after their infusion.
RELATED: What Are The Biggest Misconceptions About Ketamine Therapy?
In Conclusion
Although ketamine is not a stimulant, it is dissociative. Rather than making patients more alert and euphoric, it causes a deep feeling of relief and relaxation.
The reason behind ketamine’s effects are still unknown, but research suggests it helps rebuild brain pathways that are missing in people with depression. Ketamine’s fast-acting and long-lasting effects are what make it the increasingly sought-after alternative treatment for a wide array of mental health issues, offering hope for the millions of people affected by them.
If you or someone you care about is battling with treatment-resistant mental health issues, ketamine-assisted psychotherapy could help. Find a reliable ketamine clinic near you to find out if this promising alternative treatment can work for you.
Frequently Asked Questions
Is ketamine a stimulant or depressant?
Ketamine is classified as a dissociative anesthetic, not a stimulant or traditional depressant. It has mixed effects, producing sedation, mild dissociation, and analgesia at clinical doses while also increasing blood pressure and heart rate. It does not fit neatly into the stimulant or depressant categories.
Does ketamine give you energy?
Most patients feel mildly fatigued immediately after an infusion, then experience an energy lift in the following 24 to 48 hours as the antidepressant effects emerge. Improved sleep quality after ketamine often contributes to better daytime energy over the following week.
Is ketamine addictive like stimulants?
Therapeutic ketamine at clinical doses has low addiction potential. Recreational abuse of ketamine carries dependency risks but through different neurochemistry than stimulant addiction (amphetamines, cocaine). Clinical ketamine protocols include screening and monitoring to minimize any misuse risk.
Can ketamine improve focus?
Some patients report better focus and mental clarity in the days after ketamine therapy, likely tied to mood improvement rather than direct stimulant like effects. Ketamine is not prescribed as a focus or attention enhancer, and should not be used for ADHD without a specific psychiatric evaluation.
Ketamine’s Pharmacology in 2025: What It Is, What It Isn’t, and Why the Distinction Matters
Ketamine’s classification is a source of real confusion — it is simultaneously a Schedule III controlled substance, a licensed anesthetic, an off-label antidepressant, and a recreational drug with a dissociative character. Understanding what class it actually belongs to clarifies both how it works and what to expect from clinical use.
Ketamine is a dissociative anesthetic, not a stimulant. Stimulants (amphetamines, cocaine, caffeine) work primarily by increasing monoamine neurotransmitter activity — dopamine, norepinephrine, serotonin — producing alertness, energy, increased heart rate, and appetite suppression. Ketamine’s primary mechanism is entirely different: it is an NMDA (N-methyl-D-aspartate) receptor antagonist, blocking glutamate transmission. Glutamate is the brain’s primary excitatory neurotransmitter, and blocking NMDA receptors produces dissociation (a disconnection from ordinary sensory experience and sense of self), analgesia, and at high doses anesthesia. Ketamine belongs to the dissociative class alongside phencyclidine (PCP) and dextromethorphan (DXM) — not the stimulant class.
Why ketamine can feel activating at clinical doses. Part of the confusion about ketamine and stimulation comes from the cardiovascular effects and subjective experience at subanesthetic doses. Unlike most anesthetics (which are CNS depressants), ketamine stimulates the sympathetic nervous system: at clinical doses, it increases heart rate, blood pressure, and respiratory rate rather than suppressing them. This is why ketamine is used in emergency medicine — it maintains airway reflexes and cardiovascular stability when other anesthetics would suppress them. At subanesthetic psychiatric doses, some patients experience a sense of activation, energy, or mental clarity — particularly early in the infusion. This is distinct from stimulant pharmacology: it reflects dissociation and a temporary shift in neural processing, not monoamine release.
Ketamine in psychiatry: the 2025 landscape. Ketamine’s antidepressant properties — rapid onset (often within hours), effectiveness in treatment-resistant cases — stem from its NMDA antagonism, which triggers glutamate bursts and downstream AMPA receptor activation, BDNF release, and synaptogenesis. This is the same mechanism responsible for its rapid anti-OCD effects and its utility in suicidal ideation crises. IV ketamine is legally available off-label at thousands of ketamine clinics nationally. Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and MDD with suicidal ideation, available at certified psychiatric practices with insurance coverage. Ketamine is Schedule III — meaning it has accepted medical use and lower abuse potential than Schedule I/II substances — but it does carry addiction potential, particularly with repeated high-dose use outside clinical settings.
Frequently Asked Questions
Is ketamine a stimulant, depressant, or hallucinogen?
None of the above precisely — ketamine is classified as a dissociative anesthetic. Its primary mechanism (NMDA glutamate receptor antagonism) is distinct from stimulants (monoamine release), depressants (GABA enhancement, like alcohol/benzos), or classical hallucinogens (5-HT2A agonism, like psilocybin/LSD). At clinical doses, ketamine produces dissociation — a disconnection from ordinary sensory experience — and at higher doses anesthesia. It has unusual cardiovascular properties compared to other anesthetics: it stimulates the sympathetic nervous system, increasing heart rate and blood pressure (unlike typical depressant-class anesthetics). The DEA classifies it as Schedule III — accepted medical use, lower relative abuse potential than Schedule I/II.
How does ketamine work as an antidepressant?
Ketamine’s antidepressant mechanism is distinct from SSRIs or SNRIs (which target serotonin/norepinephrine over weeks): (1) NMDA receptor blockade triggers a glutamate “burst” — a rapid increase in glutamate activity through AMPA receptors; (2) this AMPA activation stimulates BDNF (brain-derived neurotrophic factor) release; (3) BDNF activates TrkB receptors, promoting synaptogenesis (new synapse formation) and dendritic spine growth — essentially rebuilding neural circuits that depression has pruned. This synaptic plasticity mechanism explains why ketamine works within hours rather than weeks, and why it works for patients who haven’t responded to monoamine-targeting antidepressants. The durability question is the challenge — effects typically last 2–4 weeks after a series of infusions, requiring maintenance dosing for sustained benefit.
Is ketamine addictive?
Ketamine has real addiction potential, though it is considered lower than Schedule I/II substances. Addiction risk is primarily associated with frequent recreational use at high doses — the “k-hole” pattern of use. Clinical risk factors: history of substance use disorders (particularly dissociative or depersonalization-prone individuals), psychological dependency on the dissociative state, and bladder damage with chronic heavy use (ketamine cystitis — a serious urological complication associated with daily heavy use that can require bladder surgery). In psychiatric treatment settings, with appropriate patient selection and monitored dosing intervals, addiction risk is substantially lower. Patients with active substance use disorders are typically screened out of IV ketamine programs. The FDA-approved Spravato protocol has specific REMS requirements including supervised in-clinic administration to mitigate diversion risk.
What is the difference between IV ketamine and Spravato (esketamine)?
Ketamine is a racemic mixture of two mirror-image molecules (R- and S-ketamine). Spravato is esketamine — the S-enantiomer only, delivered as a nasal spray, and FDA-approved specifically for treatment-resistant depression (TRD) and MDD with suicidal ideation. IV ketamine uses the full racemic mixture, administered intravenously at ketamine clinics — legal but off-label for psychiatric use (no FDA approval for depression). Key practical differences: (1) Insurance coverage — Spravato is often covered for FDA-approved indications; IV ketamine is almost always out-of-pocket; (2) Administration — Spravato is self-administered nasally under clinic supervision; IV ketamine requires IV placement and clinical monitoring; (3) Cost — IV ketamine series typically $3,000–$8,000 out-of-pocket; Spravato co-pays vary with insurance; (4) Evidence base — Spravato has FDA approval; IV ketamine has large evidence base but off-label status.
